Highly-cited estimates of the cumulative incidence and recurrence of vulvovaginal candidiasis are inadequately documented

BMC Women's Health

Debate

Patricia A Buffler¹  Sujit D Rathod² 

[1] Division of Epidemiology, University of California, Berkeley, USA;Division of Epidemiology, University of California, Berkeley, USA;Department of Population Health, London School of Hygiene and Tropical Medicine, London, UK;

关键词: Candidiasis;    Cumulative Incidence;    Vaginitis;    Vaginal Discharge;    Retrospective Survey;   

DOI  :  10.1186/1472-6874-14-43

 received in 2013-03-19, accepted in 2014-03-05,  发布年份 2014

来源: Springer

【 摘 要 】

BackgroundAvailable literature concerning the epidemiologic or clinical features of vulvovaginal candidiasis commonly reports that: 75% of women will experience an episode of vulvovaginal candidiasis in their lifetimes, 50% of whom will experience at least a second episode, and 5-10% of all women will experience recurrent vulvovaginal candidiasis (≥4 episodes/1 year). In this debate we traced the three commonly cited statistics to their presumed origins.DiscussionIt is apparent that these figures were inadequately documented and lacked supporting epidemiologic evidence. Population-based studies are needed to make reliable estimates of the lifetime risk of vulvovaginal candidiasis and the proportion of women who experience recurrent candidiasis.SummaryThe extent to which vulvovaginal candidiasis is a source of population-level morbidity remains uncertain.

【 授权许可】

CC BY   
© Rathod and Buffler; licensee BioMed Central Ltd. 2014